Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -490.60 | N/A |
PEG Ratio (TTM) | -6.71 | N/A |
P/S Ratio (TTM) | 3.33 | N/A |
P/B Ratio (TTM) | 3.50 | N/A |
P/FCF Ratio (TTM) | 151.62 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.33% | N/A |
ROE (TTM) | -1.00% | N/A |
Net Profit Margin (TTM) | -0.63% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 346.49% | -0.51% | N/A |
Revenue | 8.15% | 26.81% | N/A |
Net Income | 347.98% | -0.65% | N/A |
Cash Flow | 170.05% | 58.79% | N/A |
Health (47%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.62 | N/A |
Quick Ratio (TTM) | 0.77 | N/A |
D/E Ratio (TTM) | 0.55 | N/A |
Interest Coverage (TTM) | 1.14 | N/A |
Piotroski F-Score | 5 | N/A |
Altman Z-Score | 2.63 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |